|
Angelina
Tan Wei Ling
|
I am
working on the isolation and characterization of anticoagulant
proteins from salivary gland extracts of ticks.This involves
purification and structure-function studies of the novel proteins.
|
Sindhuja Sridharan
|
I work on a novel Natriuretic peptide (NP)
identified from the transcriptome of krait, called KNP. Although
KNP has evolutionarily conserved residues responsible eliciting
function, it has a distinct C-tail compared all other known
NPs. In my doctoral study I'm interested in investigating
the structure function relationship and action mechanism of
KNP.
|
Ritu
Chandna
|
The growing interests in nicotinic AcetylCholine
Receptors (nAChR) are because of their their involvement in
several important CNS pathologies. These membrane proteins
appear to be highly heterogeneous and still only little information
is available in their structure, subunit composition, and
stoichiometry. This is due to the lack of selective ligands
to study the role of nAChR under physiological or pathological
conditions. Snake venom is a good source of these ligands
and my project aims at characterization of 3 novel three-finger
toxins (3FTxs) identified from the snake Dysdalia coronoides
venom gland. Drysdalin, the longest of all the 3FTxs identified
does not possess the functionally important residues and has
a long C-terminal tail predicted to form ? - helix. Functional
characterization of drysalin shows that it is a postsynaptic
neurotoxin and irreversible antagonist to muscle nAChR, only
2.8-fold less active that the potent ?-bungarotoxin. Nanomolar
toxicity even in the absence of functionally important residues
may be attributed to the long C-terminal tail. Hence the functional
and structural characterization of the C-tail truncated drysdalin
is warranted. The other 2 novel 3FTx513V and 342 also lacks
few of the functional important residues and it is interesting
to study if these changes have occurred to bind to a new subtype
of nAChR.
|
Bidhan
Nayak
|
I am working on the structure-activity relationship
of a Phospholipase A2 enzyme from S. violaceoruber, with the
aim to design a small active scaffold of the enzyme.
|
Summer
Han Xia
|
I'm studying the transcriptional regulation of Trocarin D
from Tropidechis carinatus. To understand the transcriptional
regulation, I will identify the DNA cis-elements and interacting
protein transcription factors which regulate the expression
of Trocarin D.
|
Varuna
H.P.
|
Nicotinic acetylcholine receptors
(nAChRs) mediate ionotropic actions of acetylcholine in the
central and peripheral nervous system. Due to the lack of
highly selective nicotinic ligands, the precise location,
functional roles and various disorders associated with nAChRs
remain unclear. Neurotoxins isolated from snake venom have
a natural high affinity and selectivity to nAChRs, which act
as competitive antagonists, allosteric modulators and potential
agonists of nAChRs. These neurotoxins may therefore be invaluable
tools for studying nAChRs. In my study, a novel recombinantly
expressed 3FTx with His-tag is found to be postsynaptic reversible
neurotoxin on ex-vivo neuromuscular junction and binds to
rat muscle-type (?1)2?1?? and to rat neuronal ?4?2 and ?3?2
nAChR but has no affinity towards human ?7 receptor.
The structure-function relationships of the 3FTx will be
further investigated with series of mutants using site directed
mutagenesis approach in order to delineate its interaction
sites.
|
Iyer
Janaki Krishnamoorthy
|
My project focuses on identifying
and characterizing anticoagulants from hematophagous animals.
These include inhibitors of key players of the blood coagulation
cascade like thrombin and factor Xa. The salivary gland extracts
of ticks show very potent inhibitors of these enzymes. These
inhibitors are present in extremely low amounts in the salivary
gland extracts of these ticks. Therefore, these cannot be
purified by the traditional analytical chromatographic techniques.
Towards this, I have developed a miniaturized workflow for
on-line post-column identification of thrombin and fXa inhibitors.
In this miniaturized workflow, purification is first performed
via nano liquid chromatography and this is coupled to an on-line
assay which takes place inside a microfluidic chip in parallel
with the mass spectrometric identification of the compounds.
This technique is actually a rapid screening technique to
identify such inhibitors from complex mixtures. Therefore,
we have developed a miniaturized workflow for on-line post-column
identification of thrombin and fXa inhibitors. In this miniaturized
workflow, purification is first performed via nano liquid
chromatography and this is coupled to an on-line assay which
takes place inside a microfluidic chip in parallel with the
mass spectrometric identification of the compounds. I am working
further towards the identification of these compounds from
the salivary gland extracts of hematophagous animals.
|
Norrapat
Shih
|
My project focuses on pre-clinical studies
of Variegin, a very potent anticoagulant peptide isolated
from the tick salivary gland. Our plan is to push this peptide
into clinical trials, and eventually bring it to the market.
More specifically, I am interested in studying the pharmacokinetics
and pharmacodynamics of this peptide. With this knowledge,
we will understand the stability of this peptide drug in-vivo
and thus know the dosage required to give to patients. Furthermore,
I am also interested in selecting for DNA aptamers that can
bind to Variegin as an antidote.
|
|
|
Lab Alumni
|